Lookup NU author(s): Emeritus Professor Paul Corris
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 International Society on Thrombosis and HaemostasisBackground: Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon complication of acute pulmonary emboli necessitating lifelong anticoagulation. Despite this, few data exist on the safety and efficacy of vitamin K antagonists (VKAs) in CTEPH and none for direct oral anticoagulants (DOACs). Objectives: To evaluate outcomes and complication rates in CTEPH following pulmonary endarterectomy (PEA) for individuals receiving VKAs or DOACs. Methods: Consecutive CTEPH patients undergoing PEA between 2007 and 2018 were included in a retrospective analysis. Postoperative outcomes, recurrent venous thromboembolism (VTE), and bleeding events were obtained from patient medical records. Results: Seven hundred ninety-four individuals were treated with VKAs and 206 with DOACs following PEA. Mean observation period was 612 (standard deviation: 702) days. Significant improvements in hemodynamics and functional status were observed in both groups following PEA (P <.001). Major bleeding events were equivalent (P = 1) in those treated with VKAs (0.67%/person-year) and DOACs (0.68%/person-year). The VTE recurrence was proportionately higher (P =.008) with DOACs (4.62%/person-year) than VKAs (0.76%/person-year), although survival did not differ. Conclusions: Post-PEA functional and hemodynamic outcomes appear unaffected by anticoagulant choice. Bleeding events were similar, but recurrent VTE rates significantly higher in those receiving DOACs. Our study provides a strong rationale for prospective registry data and/or studies to evaluate the safety of DOACs in CTEPH.
Author(s): Bunclark K, Newnham M, Chiu Y-D, Ruggiero A, Villar SS, Cannon JE, Coghlan G, Corris PA, Howard L, Jenkins D, Johnson M, Kiely DG, Ng C, Screaton N, Sheares K, Taboada D, Tsui S, Wort SJ, Pepke-Zaba J, Toshner M
Publication type: Article
Publication status: Published
Journal: Journal of Thrombosis and Haemostasis
Print publication date: 01/01/2020
Online publication date: 26/09/2019
Acceptance date: 23/09/2019
ISSN (print): 1538-7933
ISSN (electronic): 1538-7836
Publisher: Blackwell Publishing Ltd
PubMed id: 31557382
Altmetrics provided by Altmetric